
Paychex Financial Ratios 2026-2007 | PAYX
Brief overview of Paychex's multiples and efficiency
This overview follows the five latest available observations from 2021 through 2025.
Market valuation is represented by P/E 31.14x (median 31.14x), EV/EBITDA 28.68x (median 16.96x), P/S 9.26x (median 9.45x). The multiple basket looks neutral against its history, differing from median levels by roughly -0.2%.
The inverse P/E implies an earnings yield of 3.2%. This is not a dividend yield, but current earnings relative to market price.
End-period return metrics are ROE 40.1%, ROA 10%, ROCE 53.5%. Current resource returns are convincing and help explain a higher market valuation.
On PEG (3.96x), valuation is stretched relative to growth and requires strong execution.
The cash cycle changed only slightly and ended at -27.7 days.
Overall assessment
Paychex trades near its familiar ratio range. A new earnings or profitability trend is needed to change the view.
Annual Financial Ratios Paychex
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
23.3 | 31.1 | 30.5 | 28.0 | 31.3 | 38.6 | 24.7 | 28.6 | 26.3 | 25.1 | 28.4 | 25.2 | 24.1 | 23.3 | 20.8 | 21.6 | 76.2 | 81.7 | 21.6 | - |
P/S |
6.3 | 9.3 | 9.8 | 8.7 | 9.5 | 10.4 | 6.7 | 7.8 | 7.3 | 6.5 | 7.3 | 6.2 | 6.0 | 5.7 | 5.1 | 5.5 | 19.9 | 20.7 | 6.0 | - |
EPS |
4.9 | 4.6 | 4.7 | 4.3 | 3.9 | 3.0 | 3.1 | 2.9 | 2.8 | 2.3 | 2.1 | 1.9 | 1.7 | 1.6 | 1.5 | 1.4 | 0.4 | 0.3 | 1.6 | - |
EV (Enterprise Value) |
52.4 B | 62.4 B | 56.7 B | 49.4 B | 49.8 B | 47.7 B | 32 B | 34.9 B | 29.6 B | 25.2 B | 25.9 B | 21.5 B | 19.6 B | 17.6 B | 16.1 B | 14.9 B | 13.7 B | 13.6 B | 12.3 B | -79.4 M |
EBITDA per Share |
8.23 | 6.71 | 6.52 | 6.13 | 5.63 | 4.59 | 4.66 | 4.32 | 3.97 | 3.8 | 3.5 | 3.2 | 2.98 | 2.76 | 2.63 | 2.29 | 0.8 | 0.77 | 2.47 | - |
EV/EBITDA |
17.7 | 25.8 | 24.1 | 22.4 | 24.5 | 28.7 | 16.2 | 19.1 | 17.0 | 14.9 | 16.9 | 14.5 | 13.8 | 13.1 | 11.8 | 13.3 | 47.3 | 48.8 | 13.5 | - |
PEG |
1.84 | 3.96 | 3.46 | 2.99 | 3.69 | 6.83 | 3.96 | 2.65 | 1.81 | 3.1 | 2.2 | 3.1 | 2.42 | 6.8 | 3.37 | 2.73 | - | - | - | - |
P/B |
11.0 | 12.5 | 13.6 | 12.5 | 14.1 | 14.4 | 9.8 | 11.3 | 12.1 | 10.5 | 11.2 | 9.5 | 8.5 | 7.5 | 7.1 | 7.4 | 7.3 | 7.7 | - | - |
P/CF |
16.1 | 27.2 | 27.2 | 25.5 | 27.4 | 33.6 | 20.7 | 25.8 | 21.9 | 23.7 | 23.3 | 21.5 | 19.0 | 23.0 | 18.4 | 18.1 | 16.7 | 14.9 | 17.2 | - |
ROE % |
47.12 | 40.15 | 44.47 | 44.58 | 45.14 | 37.23 | 39.48 | 39.49 | 46.12 | 41.80 | 39.59 | 37.80 | 35.31 | 32.08 | 34.15 | 34.44 | 9.55 | 9.39 | 48.15 | - |
ROA % |
10.88 | 10.01 | 16.28 | 14.77 | 14.46 | 11.89 | 12.84 | 11.92 | 12.51 | 11.96 | 11.75 | 10.41 | 9.85 | 9.23 | 8.46 | 9.55 | 2.56 | 2.46 | - | - |
ROCE % |
67.21 | 53.48 | 57.20 | 58.20 | 59.64 | 49.55 | 35.42 | 35.79 | 59.15 | 58.79 | 55.26 | 55.18 | 50.89 | 47.73 | 49.25 | 45.99 | 14.54 | 14.40 | 69.22 | - |
Current Ratio |
1.3 | 1.3 | 1.6 | 1.5 | 1.5 | 1.5 | 1.2 | 1.2 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.4 | 1.4 | - | - |
DSO |
- | - | - | - | - | - | 71.4 | 82.6 | 60.8 | 62.9 | 55.0 | 28.6 | 26.9 | 26.0 | 28.3 | 34.1 | 129.9 | 65.4 | - | - |
DPO |
31.0 | 27.7 | 23.3 | 23.9 | 26.2 | 24.2 | 22.6 | 23.5 | 26.7 | 22.7 | 24.1 | 23.4 | 24.3 | 23.2 | 37.4 | 25.4 | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | 71.4 | 82.6 | 60.8 | 62.9 | 55.0 | 28.6 | 26.9 | 26.0 | 28.3 | 34.1 | 129.9 | 65.4 | - | - |
Cash Conversion Cycle |
-31.0 | -27.7 | -23.3 | -23.9 | -26.2 | -24.2 | 48.8 | 59.1 | 34.1 | 40.2 | 30.8 | 5.2 | 2.6 | 2.8 | -9.0 | 8.8 | 129.9 | 65.4 | - | - |
All numbers in USD currency
Quarterly Financial Ratios Paychex
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | 2010-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
1.56 | 1.1 | 1.56 | 1.07 | - | 1.44 | 1.15 | 1.19 | - | 1.39 | 1.09 | 1.16 | - | 1.3 | 1 | 1.05 | 2.05 | 1.19 | 0.92 | 0.93 | 1.85 | 0.97 | 0.76 | 0.59 | 0.76 | 0.59 | 0.72 | 0.74 | 0.72 | 0.74 | 0.66 | 0.68 | 0.66 | 0.68 | 0.55 | 0.59 | 0.6 | 0.63 | 0.56 | 0.6 | 0.56 | 0.6 | 0.52 | 0.58 | 0.52 | 0.58 | 0.48 | 0.47 | 0.48 | 0.47 | 0.43 | 0.45 | 0.43 | 0.45 | 0.41 | 0.42 | 0.41 | 0.42 | 0.39 | 0.41 | 0.39 | 0.41 | 0.31 | 0.35 | 0.34 |
EBITDA per Share |
3.13 | 2.2 | 2.31 | 1.81 | - | 2.01 | 1.58 | 1.63 | - | 1.9 | 1.49 | 1.6 | - | 1.79 | 1.4 | 1.5 | 2.93 | 1.66 | 1.31 | 1.36 | 2.71 | 1.38 | 1.07 | 0.93 | 1.26 | 0.93 | 1.05 | 1.12 | 1.26 | 1.12 | 0.94 | 0.99 | 1.06 | 0.99 | 0.92 | 0.97 | 1.11 | 1.05 | 0.93 | 0.98 | 1.03 | 0.98 | 0.88 | 0.89 | 0.97 | 0.89 | 0.81 | 0.81 | 0.89 | 0.81 | 0.74 | 0.77 | 0.82 | 0.77 | 0.69 | 0.72 | 0.77 | 0.72 | 0.65 | 0.7 | 0.73 | 0.7 | 0.65 | 0.65 | 0.59 |
ROE % |
47.78 | 46.43 | 46.77 | 43.91 | 34.25 | 47.55 | 46.08 | 47.23 | 36.13 | 49.88 | 47.81 | 48.75 | 37.07 | 61.04 | 60.40 | 59.81 | 58.68 | 57.29 | 55.15 | 53.93 | 50.29 | 37.14 | 33.79 | 34.43 | 37.39 | 38.03 | 40.91 | 40.56 | 40.33 | 39.99 | 39.70 | 38.99 | 39.77 | 41.07 | 42.51 | 44.63 | 44.74 | 44.29 | 42.07 | 41.12 | 41.87 | 53.60 | 53.65 | 52.90 | 50.82 | 38.25 | 38.40 | 37.98 | 37.70 | 36.91 | 36.45 | 36.15 | 36.08 | 36.35 | 36.72 | 37.02 | 37.44 | 37.61 | 38.02 | 37.03 | 36.39 | 36.07 | 8.02 | 9.04 | 9.06 |
ROA % |
11.10 | 11.81 | 13.49 | 14.12 | 11.82 | 11.82 | 15.08 | 14.60 | 10.52 | 14.93 | 15.01 | 15.91 | 12.47 | 20.15 | 19.93 | 19.45 | 18.85 | 18.39 | 17.82 | 17.55 | 16.52 | 12.49 | 11.35 | 11.16 | 11.69 | 11.49 | 12.06 | 12.45 | 12.85 | 12.85 | 12.88 | 12.10 | 11.40 | 11.60 | 11.86 | 12.77 | 13.57 | 13.54 | 13.00 | 12.65 | 12.58 | 15.60 | 15.41 | 15.02 | 14.25 | 10.81 | 10.89 | 10.77 | 10.74 | 10.60 | 10.55 | 10.50 | 10.48 | 10.19 | 9.91 | 10.17 | 10.48 | 10.80 | 11.19 | 10.28 | 10.00 | 10.02 | 1.94 | 2.70 | 2.63 |
ROCE % |
67.85 | 64.93 | 63.89 | 58.36 | 44.71 | 62.05 | 59.61 | 60.85 | 46.65 | 64.64 | 62.04 | 63.47 | 48.52 | 79.90 | 79.03 | 78.41 | 77.16 | 75.75 | 74.02 | 72.17 | 67.44 | 49.75 | 44.57 | 45.61 | 49.37 | 50.41 | 54.04 | 53.41 | 53.04 | 52.41 | 51.97 | 53.04 | 56.16 | 60.36 | 64.59 | 67.98 | 67.90 | 67.30 | 66.55 | 65.25 | 65.54 | 65.74 | 65.43 | 64.33 | 62.77 | 61.50 | 59.97 | 59.36 | 58.97 | 57.78 | 57.11 | 56.53 | 56.32 | 56.64 | 57.09 | 57.52 | 58.07 | 58.30 | 58.82 | 56.88 | 55.83 | 55.17 | 12.04 | 13.87 | 13.91 |
Current Ratio |
1.3 | 1.3 | 1.3 | 1.3 | 1.3 | - | 1.6 | 1.6 | 1.6 | 1.4 | 1.4 | 1.4 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.4 | 1.4 | 1.4 | 1.4 | 1.5 | 1.5 | 1.4 | 1.4 | 1.3 | 1.3 | 1.4 | 1.4 | 1.5 | 1.5 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.3 | 1.3 | 1.5 | 1.4 | 1.4 | 1.4 | 1.3 | 1.4 | 1.4 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 702.0 | 1583.6 | 1840.2 | 1618.8 | 1451.8 | 1614.6 | 1642.9 | 1423.8 | 1310.8 | 1468.0 | 1521.6 | 1314.5 | 1217.3 | 1381.1 | 1471.0 | 1334.9 | 1299.4 | 1643.9 | 1788.3 | 1475.6 | 1373.9 | 1316.3 | 34.2 | 38.9 | - |
DPO |
28.6 | 29.9 | 26.8 | 27.6 | - | 10.5 | 20.5 | 22.2 | - | 22.4 | 23.5 | 22.8 | - | 25.6 | 21.8 | 24.8 | 13.9 | 25.6 | 22.7 | 24.5 | 12.6 | 22.1 | 18.9 | 21.0 | 22.6 | 23.1 | 19.5 | 19.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 702.0 | 1583.6 | 1840.2 | 1618.8 | 1451.8 | 1614.6 | 1642.9 | 1423.8 | 1310.8 | 1468.0 | 1521.6 | 1314.5 | 1217.3 | 1381.1 | 1471.0 | 1334.9 | 1299.4 | 1643.9 | 1788.3 | 1475.6 | 1373.9 | - | - | - | - |
Cash Conversion Cycle |
- | - | -26.8 | -27.6 | - | - | -20.5 | -22.2 | - | -22.4 | -23.5 | -22.8 | - | -25.6 | -21.8 | -24.8 | -13.9 | -25.6 | -22.7 | -24.5 | -12.6 | -22.1 | -18.9 | -21.0 | -22.6 | -23.1 | -19.5 | -19.3 | - | - | - | - | - | - | - | - | - | - | - | - | 702.0 | 1583.6 | 1840.2 | 1618.8 | 1451.8 | 1614.6 | 1642.9 | 1423.8 | 1310.8 | 1468.0 | 1521.6 | 1314.5 | 1217.3 | 1381.1 | 1471.0 | 1334.9 | 1299.4 | 1643.9 | 1788.3 | 1475.6 | 1373.9 | - | - | - | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Paychex, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Financial Ratios of other stocks in the Consulting industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
Hudson Global
HSON
|
- | 0.05 % | $ 30.3 M | ||
|
Global Internet of People
SDH
|
- | 1.0 % | $ 49.8 M | ||
|
BGSF
BGSF
|
$ 5.37 | 0.19 % | $ 59.5 M | ||
|
ASGN Incorporated
ASGN
|
- | - | $ 1.03 B | ||
|
HeadHunter Group PLC
HHR
|
- | - | - | ||
|
Forrester Research
FORR
|
$ 12.38 | 1.39 % | $ 235 M | ||
|
IHS Markit Ltd.
INFO
|
- | -1.21 % | $ 50.9 B | ||
|
51job, Inc.
JOBS
|
- | -0.05 % | $ 4.11 B | ||
|
Magal Security Systems Ltd.
MAGS
|
- | -3.95 % | $ 90.2 M | ||
|
DHI Group
DHX
|
$ 4.05 | 1.22 % | $ 181 M | ||
|
Equifax
EFX
|
$ 194.35 | 2.17 % | $ 23.9 B | ||
|
Heidrick & Struggles International
HSII
|
- | - | $ 1.2 B | ||
|
Franklin Covey Co.
FC
|
$ 20.37 | 0.1 % | $ 263 M | ||
|
Exponent
EXPO
|
$ 71.53 | 0.53 % | $ 3.64 B | ||
|
FTI Consulting
FCN
|
$ 153.74 | 1.15 % | $ 5 B | ||
|
Staffing 360 Solutions
STAF
|
- | -23.82 % | $ 7.81 M | ||
|
Nielsen Holdings plc
NLSN
|
- | 0.02 % | $ 10.1 B | ||
|
ShiftPixy
PIXY
|
- | -14.3 % | $ 3.31 M | ||
|
GEE Group
JOB
|
$ 0.25 | 0.43 % | $ 27.4 M | ||
|
Professional Diversity Network
IPDN
|
$ 0.12 | 11.12 % | $ 370 K | ||
|
Kforce
KFRC
|
$ 58.1 | 0.31 % | $ 1.03 B | ||
|
Korn Ferry
KFY
|
$ 86.28 | 1.77 % | $ 4.44 B | ||
|
7GC & Co. Holdings
VII
|
- | - | $ 124 M | ||
|
ManpowerGroup
MAN
|
$ 62.39 | 0.29 % | $ 2.91 B | ||
|
TrueBlue
TBI
|
$ 10.7 | 0.38 % | $ 319 M | ||
|
Booz Allen Hamilton Holding Corporation
BAH
|
$ 75.24 | 0.53 % | $ 9.18 B | ||
|
Cross Country Healthcare
CCRN
|
- | - | $ 429 M | ||
|
Resources Connection
RGP
|
$ 4.25 | 0.59 % | $ 143 M | ||
|
Barrett Business Services
BBSI
|
$ 34.37 | 0.64 % | $ 880 M | ||
|
Insperity
NSP
|
$ 53.54 | 3.28 % | $ 2.03 B | ||
|
HireQuest
HQI
|
$ 16.38 | 2.18 % | $ 229 M | ||
|
Robert Half International
RHI
|
$ 45.31 | 0.8 % | $ 4.54 B | ||
|
TriNet Group
TNET
|
$ 70.27 | 1.06 % | $ 3.37 B | ||
|
TransUnion
TRU
|
$ 85.67 | 1.18 % | $ 16.7 B | ||
|
Huron Consulting Group
HURN
|
$ 159.84 | 0.01 % | $ 2.79 B | ||
|
Upwork
UPWK
|
$ 9.02 | 1.12 % | $ 1.2 B | ||
|
Verisk Analytics
VRSK
|
$ 191.77 | 0.39 % | $ 26.8 B | ||
|
Volt Information Sciences, Inc.
VOLT
|
$ 35.59 | 0.12 % | $ 765 M | ||
|
Kelly Services Class B
KELYB
|
$ 23.27 | 1.22 % | $ 817 M | ||
|
Mastech Digital
MHH
|
$ 7.47 | 1.36 % | $ 87.8 M | ||
|
Greenpro Capital Corp.
GRNQ
|
$ 13.5 | 3.45 % | $ 108 M | ||
|
ICF International
ICFI
|
$ 90.22 | 0.47 % | $ 1.66 B | ||
|
Kelly Services Class A
KELYA
|
$ 17.28 | 1.11 % | $ 607 M | ||
|
CRA International
CRAI
|
$ 174.99 | 1.44 % | $ 1.16 B | ||
|
Automatic Data Processing
ADP
|
$ 287.48 | 0.98 % | $ 116 B | ||
|
Thomson Reuters Corporation
TRI
|
$ 106.23 | 1.38 % | $ 47.7 B |